SS
Sanjay Singh Sengar
About Sanjay Singh Sengar
Data last updated:
Sanjay Singh Sengar is a Director at Maple Biogenesis Private Limited (since 2023). Maple Biogenesis Private Limited reported revenue of ₹43.3 Lakh (FY 2025). Earlier, Sanjay Singh Sengar was a Director at Jancure Pharmaceuticals Private Limited (from 2014).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Maple Biogenesis Private Limited U46497MP2023PTC065091 | Director | 03 Apr 2023 | 2023 | ₹43.3 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Jancure Pharmaceuticals Private Limited U51101MH2014PTC254882 | Director | 24 Mar 2014 | 2014 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sanjay Singh Sengar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manish Modi Kumar | 02217964 | Maple Biogenesis Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Singh Sengar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Singh Sengar
Sanjay Singh Sengar currently holds 1 directorship: Maple Biogenesis Private Limited (Director, since 03 Apr 2023, revenue ₹43.3 Lakh (FY 2025)).
Sanjay Singh Sengar was first appointed on 24 Mar 2014 as Director at Jancure Pharmaceuticals Private Limited. The most recent appointment on record is 03 Apr 2023 at Maple Biogenesis Private Limited.
Sanjay Singh Sengar held 1 earlier board appointment: Jancure Pharmaceuticals Private Limited (Director, from 24 Mar 2014).
The current boards of Sanjay Singh Sengar's companies include Manish Modi Kumar (Maple Biogenesis Private Limited).